Janus kinase inhibitors: between prescription authorization and reimbursability. Reumatismo, [S. l.], v. 75, n. 4, 2023. DOI: 10.4081/reumatismo.2023.1627. Disponível em: https://www.reumatismo.org/reuma/article/view/1627. Acesso em: 13 aug. 2025.